MWVC
BMY icon

Morgens Waterfall Vintiadis & Co’s Bristol-Myers Squibb BMY Stock Holding History

Morgens Waterfall Vintiadis & Co’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-12,500
Closed -$791K – 58
2018
Q1 		$791K Buy
+12,500
New +$804K 0.6% 42

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgens Waterfall Vintiadis & Co's BMY Position: Q2 2018 in Review

Morgens Waterfall Vintiadis & Co sold out of Bristol-Myers Squibb (BMY) in Q2 2018, closing a stake of 12,500 shares — an estimated $791K sold.

Morgens Waterfall Vintiadis & Co first reported a position in BMY in Q1 2018 and held it in 1 quarter. The position peaked at $791K in Q1 2018. 1,692 funds tracked by Wall St. Rank hold BMY as of Q2 2018.

  • Morgens Waterfall Vintiadis & Co reported no remaining Bristol-Myers Squibb position as of Q2 2018 after selling out during the quarter.
  • Morgens Waterfall Vintiadis & Co sold 12,500 Bristol-Myers Squibb shares in Q2 2018, an estimated $791K.
  • Morgens Waterfall Vintiadis & Co first reported a position in Bristol-Myers Squibb in Q1 2018 and held it in 1 quarter.
  • Morgens Waterfall Vintiadis & Co's Bristol-Myers Squibb position peaked at $791K in Q1 2018.
  • 1,692 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2018.

Based on Morgens Waterfall Vintiadis & Co's 13F filing for Q2 2018, filed 14 Aug 2018.